发明名称 Chondrocyte therapeutic delivery system
摘要 Systems and methods for modifying the environment of target cell using genetically altered chondrocytes are provided. The genetically engineered chondrocytes can be used to express a therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.
申请公布号 US9125888(B2) 申请公布日期 2015.09.08
申请号 US201213719792 申请日期 2012.12.19
申请人 DEPUY MITEK, LLC 发明人 Story Brooks J.;Brown M. E. Liesbeth;Binette Francois
分类号 A61K35/32;C12N5/077;A61L27/38;A61L27/54;A61K9/00;A61K35/12 主分类号 A61K35/32
代理机构 代理人
主权项 1. A method for modifying an environment of a target cell associated with a disorder using a genetically altered chondrocyte, comprising: fully enclosing a genetically altered chondrocyte altered to express a therapeutic agent within one or more discrete semi-permeable containers, each having at least one chamber, the containers configured to retain the genetically altered chondrocyte while allowing passage of the therapeutic agent; and delivering the one or more containers to the environment of a target cell associated with a disorder; wherein the therapeutic agent is expressed and released from the one or more containers.
地址 Raynham MA US